PFIZER ($PFE) posted quarterly earnings results on Tuesday, April 29th. The company reported earnings of $0.92 per share, beating estimates of $0.70 by $0.22. The company also reported revenue of $13,715,000,000, missing estimates of $14,398,643,042 by $-683,643,042.
You can see Quiver Quantitative's $PFE stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PFIZER Insider Trading Activity
PFIZER insiders have traded $PFE stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PFE stock by insiders over the last 6 months:
- RONALD E BLAYLOCK purchased 19,457 shares for an estimated $499,072
- JENNIFER B. DAMICO (SVP & Controller) sold 2,500 shares for an estimated $64,825
- SCOTT GOTTLIEB purchased 1,000 shares for an estimated $28,240
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PFIZER Hedge Fund Activity
We have seen 1,172 institutional investors add shares of PFIZER stock to their portfolio, and 1,619 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 25,315,159 shares (+19.5%) to their portfolio in Q4 2024, for an estimated $671,611,168
- WELLINGTON MANAGEMENT GROUP LLP removed 23,736,431 shares (-14.5%) from their portfolio in Q4 2024, for an estimated $629,727,514
- BLACKROCK, INC. added 15,738,757 shares (+3.6%) to their portfolio in Q4 2024, for an estimated $417,549,223
- STARBOARD VALUE LP added 15,368,658 shares (+inf%) to their portfolio in Q4 2024, for an estimated $407,730,496
- MILLENNIUM MANAGEMENT LLC removed 12,434,525 shares (-80.4%) from their portfolio in Q4 2024, for an estimated $329,887,948
- AMUNDI removed 10,800,352 shares (-22.9%) from their portfolio in Q4 2024, for an estimated $286,533,338
- BARCLAYS PLC removed 10,203,305 shares (-37.7%) from their portfolio in Q4 2024, for an estimated $270,693,681
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PFIZER Government Contracts
We have seen $5,046,380 of award payments to $PFE over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- THE PURPOSE OF THIS DELIVERY ORDER IS TO PROCURE PHARMACEUTICALS TO REPLENISH EXPIRED PRODUCT.: $2,151,230
- STERILE WATER FOR INJECTION 20ML: $1,167,976
- 8510849631!OTHER MEDICAL: $924,719
- PFIZER VACCINES STORAGE AND ROTATION CONTRACT: $410,203
- CIPROFLOXACIN: $243,101
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
PFIZER Congressional Stock Trading
Members of Congress have traded $PFE stock 10 times in the past 6 months. Of those trades, 4 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 02/26 and 2 sales worth up to $65,000 on 03/31, 01/24.
- REPRESENTATIVE CAROL D. MILLER sold up to $15,000 on 03/10.
- REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $50,000 on 02/25.
- REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 02/24.
- SENATOR JOHN BOOZMAN sold up to $15,000 on 02/13.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 02/12, 01/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PFIZER Price Targets
Multiple analysts have issued price targets for $PFE recently. We have seen 2 analysts offer price targets for $PFE in the last 6 months, with a median target of $28.0.
Here are some recent targets:
- Carter Gould from Cantor Fitzgerald set a target price of $24.0 on 04/22/2025
- Robyn Karnauskas from Truist Financial set a target price of $32.0 on 12/18/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
